221 related articles for article (PubMed ID: 28750683)
1. Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network.
Dhingra P; Martinez-Fundichely A; Berger A; Huang FW; Forbes AN; Liu EM; Liu D; Sboner A; Tamayo P; Rickman DS; Rubin MA; Khurana E
Genome Biol; 2017 Jul; 18(1):141. PubMed ID: 28750683
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
Simmonds P; Loomis E; Curry E
Genome Med; 2017 Jun; 9(1):54. PubMed ID: 28592290
[TBL] [Abstract][Full Text] [Related]
3. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
Rose M; Schubert C; Dierichs L; Gaisa NT; Heer M; Heidenreich A; Knüchel R; Dahl E
Epigenetics; 2014 Dec; 9(12):1626-40. PubMed ID: 25625847
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
6. HES5 silencing is an early and recurrent change in prostate tumourigenesis.
Massie CE; Spiteri I; Ross-Adams H; Luxton H; Kay J; Whitaker HC; Dunning MJ; Lamb AD; Ramos-Montoya A; Brewer DS; Cooper CS; Eeles R; ; Warren AY; Tavaré S; Neal DE; Lynch AG
Endocr Relat Cancer; 2015 Apr; 22(2):131-44. PubMed ID: 25560400
[TBL] [Abstract][Full Text] [Related]
7. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
8. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
Huang D; Ovcharenko I
BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
[TBL] [Abstract][Full Text] [Related]
10. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
Jin HJ; Jung S; DebRoy AR; Davuluri RV
Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.
Aryee MJ; Liu W; Engelmann JC; Nuhn P; Gurel M; Haffner MC; Esopi D; Irizarry RA; Getzenberg RH; Nelson WG; Luo J; Xu J; Isaacs WB; Bova GS; Yegnasubramanian S
Sci Transl Med; 2013 Jan; 5(169):169ra10. PubMed ID: 23345608
[TBL] [Abstract][Full Text] [Related]
13. Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.
Ngollo M; Lebert A; Daures M; Judes G; Rifai K; Dubois L; Kemeny JL; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
BMC Cancer; 2017 Apr; 17(1):261. PubMed ID: 28403887
[TBL] [Abstract][Full Text] [Related]
14. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract][Full Text] [Related]
15. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.
Ross-Adams H; Ball S; Lawrenson K; Halim S; Russell R; Wells C; Strand SH; Ørntoft TF; Larson M; Armasu S; Massie CE; Asim M; Mortensen MM; Borre M; Woodfine K; Warren AY; Lamb AD; Kay J; Whitaker H; Ramos-Montoya A; Murrell A; Sørensen KD; Fridley BL; Goode EL; Gayther SA; Masters J; Neal DE; Mills IG
Oncotarget; 2016 Nov; 7(46):74734-74746. PubMed ID: 27732966
[TBL] [Abstract][Full Text] [Related]
16. Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis.
Kamdar SN; Ho LT; Kron KJ; Isserlin R; van der Kwast T; Zlotta AR; Fleshner NE; Bader G; Bapat B
Clin Epigenetics; 2016; 8():32. PubMed ID: 26981160
[TBL] [Abstract][Full Text] [Related]
17. Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.
Kumar SR; Bryan JN; Esebua M; Amos-Landgraf J; May TJ
BMC Cancer; 2017 Feb; 17(1):158. PubMed ID: 28235398
[TBL] [Abstract][Full Text] [Related]
18. Robust gene network analysis reveals alteration of the STAT5a network as a hallmark of prostate cancer.
Reddy A; Huang CC; Liu H; Delisi C; Nevalainen MT; Szalma S; Bhanot G
Genome Inform; 2010; 24():139-53. PubMed ID: 22081596
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer.
Kim SJ; Kelly WK; Fu A; Haines K; Hoffman A; Zheng T; Zhu Y
Cancer Lett; 2011 Mar; 302(1):47-53. PubMed ID: 21237555
[TBL] [Abstract][Full Text] [Related]
20. IDPT: Insights into potential intrinsically disordered proteins through transcriptomic analysis of genes for prostate carcinoma epigenetic data.
Mallik S; Sen S; Maulik U
Gene; 2016 Jul; 586(1):87-96. PubMed ID: 27060408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]